Flagship Harbor Advisors LLC Sells 1,871 Shares of UnitedHealth Group Incorporated $UNH

Flagship Harbor Advisors LLC lowered its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 14.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 11,269 shares of the healthcare conglomerate’s stock after selling 1,871 shares during the period. Flagship Harbor Advisors LLC’s holdings in UnitedHealth Group were worth $3,720,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of UNH. Guerra Advisors Inc purchased a new position in UnitedHealth Group in the 3rd quarter worth about $1,059,000. Berkshire Hathaway Inc bought a new position in shares of UnitedHealth Group during the 2nd quarter valued at approximately $1,572,193,000. Carnegie Investment Counsel boosted its stake in UnitedHealth Group by 2.2% in the 3rd quarter. Carnegie Investment Counsel now owns 105,621 shares of the healthcare conglomerate’s stock worth $36,471,000 after purchasing an additional 2,316 shares during the period. Phoenix Financial Ltd. raised its holdings in shares of UnitedHealth Group by 111.5% during the 3rd quarter. Phoenix Financial Ltd. now owns 41,986 shares of the healthcare conglomerate’s stock worth $14,282,000 after acquiring an additional 22,137 shares in the last quarter. Finally, Money Concepts Capital Corp raised its holdings in shares of UnitedHealth Group by 59.1% during the 3rd quarter. Money Concepts Capital Corp now owns 12,380 shares of the healthcare conglomerate’s stock worth $4,275,000 after acquiring an additional 4,600 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 1.5%

UnitedHealth Group stock opened at $281.46 on Tuesday. The stock has a market capitalization of $255.48 billion, a PE ratio of 21.34, a price-to-earnings-growth ratio of 1.28 and a beta of 0.40. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $606.36. The business has a 50 day simple moving average of $281.61 and a 200-day simple moving average of $319.24. The company has a debt-to-equity ratio of 0.72, a current ratio of 0.79 and a quick ratio of 0.79.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, January 27th. The healthcare conglomerate reported $2.11 EPS for the quarter, beating analysts’ consensus estimates of $2.09 by $0.02. The business had revenue of $113.73 billion during the quarter, compared to analysts’ expectations of $113.38 billion. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The business’s revenue was up 12.3% compared to the same quarter last year. During the same period in the previous year, the business earned $6.81 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. On average, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 17th. Stockholders of record on Monday, March 9th were paid a $2.21 dividend. The ex-dividend date of this dividend was Monday, March 9th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 3.1%. UnitedHealth Group’s payout ratio is currently 67.02%.

Key Headlines Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: CMS finalized a materially larger-than-expected Medicare Advantage payment increase for 2027 (~2.48%), adding about $13 billion industrywide. This directly benefits UnitedHealth given its scale in MA plans and improves revenue/margin outlook for the business. Trump administration finalizes better-than-feared Medicare Advantage payment rate
• Positive Sentiment: Reports note Medicare Advantage payments will rise ~2.5% in 2027, above earlier estimates — a direct tailwind for UNH’s Medicare Advantage revenue and cash flow profile. UnitedHealth, Humana, Health Insurers Jump On Higher Medicare Advantage Payments
• Positive Sentiment: Coverage pieces highlight the size of the MA market (~35M members) and why the new payment baseline is a big deal for healthcare insurers, reinforcing investor optimism on UNH’s core growth engine. New Medicare Payment Rate Expected. Why It’s a Big Deal for Healthcare Stocks.
• Positive Sentiment: Raymond James upgraded/boosted its rating on UNH ahead of Q1 results, providing analyst support into the earnings period and helping lift sentiment. Raymond James Boosts UnitedHealth (UNH) Rating Before Q1 Results
• Neutral Sentiment: Pre-earnings previews and commentary note UNH enters Q1 reporting (Apr 21) with weak guidance last quarter but still broad analyst support — the upcoming print is a near-term catalyst. UnitedHealth Q1 Earnings Preview: What To Expect From Upcoming Report
• Neutral Sentiment: Preview/market pieces flag April 21 as a make-or-break quarter for validating management’s recovery narrative after a turbulent year. Earnings outcome will likely drive the next leg of the stock’s move. Is April 21 When UnitedHealth Group Finally Sheds Its Problem Past?
• Negative Sentiment: Analyst/market commentary warns of recent weakness — UNH has fallen materially over the past six months after softer results and below-trend guidance; downside risks remain if Q1 disappoints or regulatory/ margin pressures persist. 2 Reasons to Watch UNH and 1 to Stay Cautious

Wall Street Analyst Weigh In

Several analysts recently weighed in on the company. UBS Group decreased their price target on UnitedHealth Group from $430.00 to $410.00 and set a “buy” rating on the stock in a report on Wednesday, January 28th. Royal Bank Of Canada cut their price target on UnitedHealth Group from $408.00 to $361.00 and set an “outperform” rating on the stock in a research note on Wednesday, January 28th. Sanford C. Bernstein reaffirmed an “outperform” rating on shares of UnitedHealth Group in a research report on Wednesday, January 28th. Jefferies Financial Group lowered their price target on UnitedHealth Group from $418.00 to $340.00 and set a “buy” rating for the company in a report on Wednesday, January 28th. Finally, Raymond James Financial raised UnitedHealth Group from a “market perform” rating to an “outperform” rating and set a $330.00 target price for the company in a report on Wednesday, April 1st. One research analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating, seven have given a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $363.38.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.